bf/NASDAQ:RGLS_icon.jpeg

COM:REGULUSRX

Regulus Therapeutics

  • Stock

Last Close

1.55

25/09 14:38

Market Cap

115.22M

Beta: -

Volume Today

48.06K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
19.57M
-
7.67M
60.81%
20.76M
170.69%
1.19M
94.25%
72K
93.97%
72K
0%
6.83M
9,388.89%
10.01M
46.46%
cost of revenue
12.35K
-
15.35K
24.28%
459K
2,890.81%
122K
73.42%
227K
86.07%
gross profit
19.57M
-
7.67M
60.81%
20.76M
170.69%
1.19M
94.25%
72K
93.97%
72K
0%
6.82M
9,371.74%
9.99M
46.50%
-459K
104.59%
-122K
73.42%
-227K
86.07%
selling and marketing expenses
-82K
-
general and administrative expenses
7.43M
-
11.53M
55.24%
19.13M
65.87%
18.39M
3.86%
17.01M
7.50%
12.86M
24.40%
11.32M
12.00%
8.81M
22.12%
10.02M
13.71%
9.83M
1.93%
9.96M
1.30%
selling general and administrative expenses
7.43M
-
11.53M
55.24%
19.13M
65.87%
18.39M
3.86%
17.01M
7.50%
12.86M
24.40%
11.32M
12.00%
8.81M
22.12%
10.02M
13.71%
9.83M
1.93%
9.88M
0.47%
research and development expenses
29.94M
-
41.05M
37.09%
56.39M
37.38%
64.31M
14.04%
53.19M
17.28%
33.98M
36.13%
12.35M
63.65%
15.35M
24.28%
17.79M
15.94%
18.41M
3.46%
21.01M
14.11%
other expenses
-1.88M
-
-1.76M
6.74%
-1.57M
10.36%
9K
100.57%
-83K
1,022.22%
cost and expenses
37.37M
-
52.58M
40.69%
75.52M
43.63%
82.70M
9.51%
70.20M
15.11%
46.84M
33.29%
23.67M
49.47%
24.16M
2.09%
27.82M
15.13%
28.24M
1.52%
31.11M
10.16%
operating expenses
37.37M
-
52.58M
40.69%
75.52M
43.63%
82.70M
9.51%
70.20M
15.11%
46.84M
33.29%
23.67M
49.47%
24.16M
2.09%
27.82M
15.13%
28.24M
1.52%
30.88M
9.36%
interest expense
36K
-
39K
8.33%
52K
33.33%
1.18M
2,173.08%
2.72M
130.37%
2.34M
13.96%
2.13M
9.05%
1.81M
15.16%
855K
52.71%
688K
19.53%
604K
12.21%
ebitda
-16.91M
-
-33.14M
95.95%
-53.75M
62.19%
-81.16M
51.00%
-68.16M
16.02%
-46.76M
31.39%
-16.83M
64.00%
-14.15M
15.91%
-27.82M
96.51%
-28.24M
1.52%
-30.88M
9.36%
operating income
-17.80M
-
-44.91M
152.28%
-54.76M
21.93%
-81.50M
48.84%
-70.13M
13.95%
-46.76M
33.32%
-16.83M
64.00%
-14.15M
15.91%
-27.82M
96.51%
-28.24M
1.52%
-31.11M
10.16%
depreciation and amortization
1.36M
-
1.49M
9.56%
1.59M
6.78%
2.28M
43.05%
2.52M
10.90%
2.26M
10.38%
931K
58.84%
467K
49.84%
459K
1.71%
122K
73.42%
227K
86.07%
total other income expenses net
-889K
-
-11.77M
1,223.85%
-1.01M
91.44%
-338K
66.47%
-1.97M
483.14%
-1.88M
4.41%
-1.76M
6.74%
-1.57M
10.36%
9K
100.57%
-83K
1,022.22%
1.07M
1,392.77%
income before tax
-18.69M
-
-56.68M
203.24%
-55.77M
1.61%
-81.84M
46.76%
-72.10M
11.90%
-48.65M
32.53%
-18.59M
61.78%
-15.73M
15.39%
-27.81M
76.78%
-28.32M
1.85%
-30.04M
6.05%
income tax expense
-23K
-
1K
104.35%
-18K
1,900%
-4K
77.78%
-197K
4,825%
62K
131.47%
1K
98.39%
-467K
46,800%
1K
100.21%
1K
0%
1K
0%
net income
-18.67M
-
-56.68M
203.62%
-55.75M
1.64%
-81.84M
46.80%
-71.91M
12.14%
-48.71M
32.26%
-18.59M
61.83%
-15.26M
17.91%
-27.81M
82.19%
-28.32M
1.85%
-30.04M
6.05%
weighted average shs out
320.66K
-
367.42K
14.58%
428.43K
16.61%
440.11K
2.73%
626.92K
42.45%
871.86K
39.07%
1.73M
97.97%
3.50M
102.65%
8.57M
145.03%
15.26M
78.05%
18.96M
24.25%
weighted average shs out dil
320.66K
-
367.42K
14.58%
428.43K
16.61%
440.11K
2.73%
626.92K
42.45%
871.86K
39.07%
1.73M
97.97%
3.50M
102.65%
8.57M
145.03%
15.26M
78.05%
18.96M
24.25%
eps
-58.22
-
-154.27
164.98%
-130.12
15.65%
-185.94
42.90%
-114.70
38.31%
-55.87
51.29%
-10.77
80.72%
-4.36
59.52%
-3.24
25.69%
-1.86
42.59%
-1.58
15.05%
epsdiluted
-58.22
-
-154.27
164.98%
-130.12
15.65%
-185.94
42.90%
-114.70
38.31%
-55.87
51.29%
-10.77
80.72%
-4.36
59.52%
-3.24
25.69%
-1.86
42.59%
-1.58
15.05%

All numbers in (except ratios and percentages)